Dear Ana, thanks for the detailed explanation, and the new draft. I took the liberty to subscribe others copied on this e-mail to our Myotoxin-II discussion list since this is very valuable information informing our planned experiments (you all should have received a notification of being subscribed to "myotox@biophysics.uleth.ca", which everyone should use to correspond on this topic. You can find more information on this mailing list and manage your own subscription at: https://www.biophysics.uleth.ca/mailman/listinfo/myotox) In light of the information from Ana I would strongly suggest to start with AUC experiments in the presence of lipids or SDS to see if we can simulate this induced dimerization by adding different lipids in small amounts (probably below CMC for easier interpretation). AUC will tell us how heterogeneous the mixtures are and if this is sufficient purity to expect useful data from a SAXS experiment. In any case, it will be straightforward and probably require less material to test if we test myotoxin-II by AUC in the presence of the lipids you mentioned. Perhaps as a first try we could measure the remaining amount of myotoxin at an intermediate concentration by titrating SDS into the mixture and see if this induces dimerization. If this works, we could also try some of the other lipids Anna mentioned. If there is not enough material, perhaps Bruno's lab could purify some more and send it to us. Amy will be back after the new year and can check into the remaining amounts. It is possible this was already passed on to Tony's lab for NMR experiments. How does that sound? -Borries Date: Thu, 26 Dec 2019 15:44:59 -0300 From: Ana Gisele da Costa Neves Ferreira <anagextra@gmail.com> To: Borries Demeler <demeler@gmail.com>, Bruno Lomonte <bruno.lomonte@ucr.ac.cr>, Chico - UFRJ <gomes.netof@gmail.com>, "Henrickson, Amy" <amy.henrickson@uleth.ca>, Julian Fernandez Ulate <jfu273b@gmail.com>, Emre Brookes <emre.brookes@umontana.edu>, Richard <richardhemmi@gmail.com>, Thomas Jorgensen <tjdj@bmb.sdu.dk>, Tatiana Brasil <tatiana.brasil@gmail.com>, Ana Gisele gmail <anagextra@gmail.com> Subject: Fwd: First draft - monomeric Mt-II Dear co-authors, My comments/suggestions follow in the attached v03_AnaG draft. Since we have recently decided to publish the AUC data on the myotoxin separated from the data on the interaction with DM64, I´ve also included the names of Tatiana (SAXS analysis) and Richard/Thomas (MS analysis) as co-authors of this first paper (I have CC´d them on this email as well). As for molecular dynamics experiments (Tati, Richard and Thomas, please read the emails below to catch up with the story), Chico will need additional 2-3 weeks to have a better idea of the behavior of the "dimeric" myotoxin, he has just started to define the settings for the MD runs. Borries, regarding SAXS experiments on myotoxin in the presence of fatty acids, the literature on PLA2-like proteins (mainly based on crystal studies) assumes that dimerization of the toxin is key to toxicity. The hypothesis (still controversial) is that the toxins could exist as monomers in solution or as inactive dimers. The binding of fatty acids at their hydrophobic channel would induce monomer dimerization and/or allosteric changes from inactive ("conventional/unbound") to active ("alternative/bound") dimers. The conformational change would occur through a molecular hinge, leading the bound toxins to expose/align a cationic "Membrane-Docking Site" (MDoS) and a hydrophobic "Membrane-Disruption Site (MDiS), which disrupts the lipid bilayer. Several PLA2-like structures have been solved in the absence/presence of saturated fatty acids [ex.: lauric acid (C12), myristic acid (C14), stearic acid (C18)], allowing for the study of these different oligomeric conformations (see attached review by Bruno and co-authors 2014). I have also attached a more recent paper in which the authors have used SDS (as a fatty acid mimetic) to trigger myotoxin oligomerization. Interestingly, they have monitored the oligomerization by AUC (Matsui 2019). In summary, either by SAXS and/or AUC, I think it would be nice to test for oligomerization in the presence of fatty acids/SDS. In any case, the AUC and SAXS data we already have clearly contradict the belief that myotoxin II exists as a "highly stable dimer in solution"; the papers that support this hypothesis were mainly based on electrophoresis and X-ray crystallography experiments. If I´m not wrong (Bruno ?), they were all run in the absence of fatty acids, just like we have done. Best regards and happy new year ! Ana ---------- Forwarded message --------- De: Ana Gisele da Costa Neves Ferreira <anagextra@gmail.com> Date: dom., 22 de dez. de 2019 às 12:25 Subject: Re: first draft - monomeric Mt-II To: Bruno Lomonte <bruno.lomonte@ucr.ac.cr> Cc: Borries Demeler <demeler@gmail.com>, Chico - UFRJ <gomes.netof@gmail.com>, Amy Henrickson <amy.henrickson@uleth.ca>, Julian Fernandez Ulate < jfu273b@gmail.com>, Emre Brookes <emre.brookes@umontana.edu> Dear colleagues, I apologize for not having had time to touch the manuscript last week, I´m doing this today/tomorrow and will send my suggestions/comments as soon as possible. Best regards, AnaG Em sáb., 14 de dez. de 2019 às 02:02, Bruno Lomonte <bruno.lomonte@ucr.ac.cr> escreveu:
Hi all,
here is the v.03 draft, reorganized after Borries' additions, so we can use this new (provisional) version to add the data from Ana G and Chico
best regards to all,
Bruno
+++
On 13/12/2019 11:15, Borries Demeler wrote:
Bruno, that sounds good. Let me see when we can get beamline access. I may have you send the SAXS samples to the beamline directly.
Emre: would you have some beamline access available to get a myotoxin sample in phosphate buffer analyzed? If not, we could also do it with Trushar at the Saskatoon beamline.
Ana: I am not clear on the purpose of running SAXS experiments on myotoxin in the presence of fatty acids, can you explain the reasoning behind this?
Thanks, -Borries
On Thu, Dec 12, 2019 at 10:38:52PM -0600, Bruno Lomonte wrote:
Great additions Borries! let me adjust the formatting (BBRC style) and generate the next file (v.03) to pass it over to Ana G and Chico
as for the toxin, we better prepare a new batch to send it to you in January, to use it in both SAXS and the NMR explorations - Julian and I will work on it after the holidays break, and coordinate with Amy like before
looking forward also to the MD simulations by Chico! great...
all the best,
Bruno
++++
On 12/12/2019 22:06, Borries Demeler wrote:
Dear all, Attached is a second version that includes the AUC analysis results and figures, and new endnotes/references.
I changed the author order around a bit, putting Amy first who did the majority of this AUC work.
Ana, I don't think we have enough material left to do SAXS analysis, plus we were going to use what we do have for preliminary NMR experiments. The MD results would be very useful, especially if they show monomer :)
Best wishes, -Borries
On Thu, Dec 12, 2019 at 04:54:12PM -0300, Ana Gisele da Costa Neves Ferreira wrote:
Dear Bruno, Thank you for the first draft, I´ve already taken a quick read. I´ll complete the text parts regarding AUC and SAXS results in the next few days (they will be deleted from the DM64 manuscript). I talked to Chico (cc) earlier today and he came with two nice suggestions to enrich the paper: 1) He will try to run a molecular dynamics simulation on the dimeric structure of myotoxin-II to investigate its behavior over time; 2) Borries, if you have enough myotoxin-II left, do you think it would be possible to ask your colleagues in the US to repeat the SAXS analysis in the presence/absence of fatty acids ? If possible, we would check which fatty acids/conditions to assay. Best regards, Ana
Em qua., 11 de dez. de 2019 às 01:57, Bruno Lomonte < bruno.lomonte@ucr.ac.cr> escreveu:
Dear Ana Gisele and Borries,
I have tried to put together some ideas, in case we would like to present the evidence for a momomeric state in solution for the Mt-II, in a short note
I have evaluated the possibilities of getting further proteins of this type in sufficient quantities, to expland our findings, but concluded that it was not feasible for the moment
So please give it a thought if you think it is worth to try to communicate this first, before the larger study on the DM64-MtII interaction. I believe this manuscript could go to Biochem Biophys Res Comm, but if you have any other thoughts they will be welcome
I anticipate that evaluation may not be so easy, since the findings go against the widely accepted idea on the dimer state, and might imply a substantial change in the view on how these toxins function - many years, many articles... experts may not be too happy :) but this is science anyway...
You both would need to prepare the methods section and the results section, and integrate with the general discussion
Please consider that this is just a very first draft, a starting point - modify at will !!! especially my poor English!!!
Let me hear your thoughts,
with best wishes for the holydays,
Bruno
-- Bruno Lomonte, Ph.D. Instituto Clodomiro Picado Universidad de Costa Rica San José, 11501 COSTA RICA
bruno.lomonte@ucr.ac.cr tel. +506 2511 7888 cel. +506 8392 0012
-- Ana Gisele da C. Neves Ferreira Pesquisadora Titular em Saúde Pública Chefe do Laboratorio de Toxinologia Instituto Oswaldo Cruz - Fiocruz Pavilhao Ozorio de Almeida, sala 05 Av. Brasil, 4365 - Manguinhos Rio de Janeiro - RJ 21040-900 Brasil (+5521) 2562-1381 / 98801-5726 -- Bruno Lomonte, Ph.D. Instituto Clodomiro Picado Universidad de Costa Rica San José, 11501 COSTA RICA
bruno.lomonte@ucr.ac.cr tel. +506 2511 7888 cel. +506 8392 0012
-- Bruno Lomonte, Ph.D. Instituto Clodomiro Picado Universidad de Costa Rica San José, 11501 COSTA RICA
bruno.lomonte@ucr.ac.cr tel. +506 2511 7888 cel. +506 8392 0012
-- Ana Gisele da C. Neves Ferreira Pesquisadora Titular em Saúde Pública Chefe do Laboratorio de Toxinologia Instituto Oswaldo Cruz - Fiocruz Pavilhao Ozorio de Almeida, sala 05 Av. Brasil, 4365 - Manguinhos Rio de Janeiro - RJ 21040-900 Brasil (+5521) 2562-1381 / 98801-5726 -- Ana Gisele da C. Neves Ferreira Pesquisadora Titular em Saúde Pública Chefe do Laboratorio de Toxinologia Instituto Oswaldo Cruz - Fiocruz Pavilhao Ozorio de Almeida, sala 05 Av. Brasil, 4365 - Manguinhos Rio de Janeiro - RJ 21040-900 Brasil (+5521) 2562-1381 / 98801-5726 -- Ana Gisele da C. Neves Ferreira Pesquisadora Titular em Saúde Pública Chefe do Laboratorio de Toxinologia Instituto Oswaldo Cruz - Fiocruz Pavilhao Ozorio de Almeida, sala 05 Av. Brasil, 4365 - Manguinhos Rio de Janeiro - RJ 21040-900 Brasil (+5521) 2562-1381 / 98801-5726 -- Ana Gisele da C. Neves Ferreira Pesquisadora Titular em Saúde Pública Chefe do Laboratorio de Toxinologia Instituto Oswaldo Cruz - Fiocruz Pavilhao Ozorio de Almeida, sala 05 Av. Brasil, 4365 - Manguinhos Rio de Janeiro - RJ 21040-900 Brasil (+5521) 2562-1381 / 98801-5726 -- Ana Gisele da C. Neves Ferreira Pesquisadora Titular em Saúde Pública Chefe do Laboratorio de Toxinologia Instituto Oswaldo Cruz - Fiocruz Pavilhao Ozorio de Almeida, sala 05 Av. Brasil, 4365 - Manguinhos Rio de Janeiro - RJ 21040-900 Brasil (+5521) 2562-1381 / 98801-5726 ----- End forwarded message -----